For instance, a recent clinical trial demonstrated that the Bushen Yinao pill, a TCM compound formulation, when combined with conventional therapy, significantly modulates gut microbiota composition (increasing beneficial and decreasing harmful bacteria), reduces key inflammatory markers (IL-6 and TNF-α), and improves cognitive function in elderly patients with AD (Wang et al., 2025). Here, TNF is linked to Alzheimer disease.